Samsung to Invest $1.5 Billion in Vietnam Semiconductor Testing Plant by 2027 
MongoDB Q1 FY2027 Earnings Beat Expectations, Raises Full-Year Outlook 
Dell Raises 2027 Revenue Forecast as AI Server Demand Drives Record Quarterly Results 
Marvell Stock Rises After Record Q1 FY2027 Earnings Fueled by AI Demand 
US Quantum Stocks Surge After $2 Billion Government Investment 
Elon Musk Explores Possible Tesla-SpaceX Merger Amid Growing AI Investments 
Meta Subscription Push Could Add Billions in Recurring Revenue, Says Rosenblatt 
Costco Q3 Fiscal 2026 Earnings Beat Expectations as Sales and E-Commerce Surge 
Kentucky School District Secures $27 Million in Social Media Addiction Lawsuit Settlements 
Universal Music Group Rejects Pershing Square Takeover Proposal 
Sable Offshore Wins Key Court Battle Over California Oil Pipeline 
Samsung Union Dispute Escalates Over Semiconductor Bonus Vote 
HP Q2 2026 Earnings Beat Expectations Despite Memory Chip Pressure 
Salesforce Q1 FY2027 Earnings Beat Expectations Despite Soft Q2 Revenue Outlook 
JPMorgan Sees Biotech Sector at Turning Point, Upgrades Top Pharma Stocks 
SK Hynix Joins $1 Trillion Club as AI Chip Demand Fuels Stock Surge 
Australia Sues 3M for Over A$2 Billion Over PFAS Firefighting Foam Contamination 
Pompano Beach, Fla., Dec. 09, 2015 (GLOBE NEWSWIRE) -- DS Healthcare Group’s flagship products are now selling in Walmart, one of Brazil’s largest retailers. With this addition, DS Laboratories further expands its global retail footprint as part of the company’s omni-channel approach and continued dedication to delivering its breakthroughs to consumers worldwide.
Brazilian customers can view our product selection and order at the following link: https://www.walmart.com.br/busca/?ft=ds+laboratories&PS=20
Brazil remains the world's third largest consumer market for toiletries and stands as the world’s second largest market for men’s and children’s hair care products. The partnership with Walmart is expected to drive significant revenue growth for the company in Brazil.
About DS Healthcare Group
DS Healthcare Group Inc. is a leader in the development of biotechnology for topical therapies. It markets through online channels, specialty retailers, distributors, pharmacies, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Health Group's flagship brand, visit www.dslaboratories.com or www.facebook.com/DS.Labs
Forward-looking statements
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov
Investor Relations DS Healthcare Group (888) 404-7770 ext. 3 [email protected]
